{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:09:15Z","timestamp":1745467755827,"version":"3.40.4"},"reference-count":50,"publisher":"Media Sphere Publishing House","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rus. Ann. Ophthal."],"published-print":{"date-parts":[[2024,4,23]]},"abstract":"<jats:p>Age-related macular degeneration (AMD) is a chronic multifactorial degenerative eye disease and one of the leading causes of irreversible blindness worldwide. Despite extensive research, there is no consensus on the predominant pathological mechanism leading to photoreceptor death. AMD is associated with molecular and cellular disruptions that ultimately result in photoreceptor degeneration. This review summarizes data from international and Russian studies on the pathophysiological mechanisms underlying the development and progression of photoreceptor degeneration, presents scientific developments in therapeutic correction of these disturbances, and highlights promising avenues for pharmacological retinal neuroprotection that require further validation in clinical studies.<\/jats:p>","DOI":"10.17116\/oftalma2024140061152","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T05:49:26Z","timestamp":1735364966000},"page":"152","source":"Crossref","is-referenced-by-count":0,"title":["Neuroprotective therapy for age-related macular degeneration"],"prefix":"10.17116","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6835-3393","authenticated-orcid":false,"given":"A.S.","family":"Vlasova","sequence":"first","affiliation":[{"name":"West Siberian Institute of Postgraduate Medical Education","place":["Tyumen, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1566-2299","authenticated-orcid":false,"given":"S.A.","family":"Petrov","sequence":"additional","affiliation":[{"name":"West Siberian Institute of Postgraduate Medical Education","place":["Tyumen, Russia"]},{"name":"Tyumen Scientific Center of the Siberian Branch of the Russian Academy of Sciences","place":["Tyumen, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2258-2207","authenticated-orcid":false,"given":"E.V.","family":"Renzyak","sequence":"additional","affiliation":[{"name":"West Siberian Institute of Postgraduate Medical Education","place":["Tyumen, Russia"]},{"name":"District Clinical Hospital of the Khanty-Mansiysk Autonomous Okrug \u2014 Yugra","place":["Khanty-Mansiysk, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-1","DOI":"10.1186\/s40662-016-0063-5"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-2","DOI":"10.1001\/jama.2023.26074"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-3","DOI":"10.1136\/bjophthalmol-2019-314422"},{"unstructured":"Neroev VV. Features of ophthalmological morbidity in the Russian Federation. Belye nochi 2024. Accessed 03.09.2024 (In Russ.). https:\/\/igb.ru\/docs\/%D0%94%D0%BE%D0%BA%D0%BB%D0%B0%D0%B4%20%D0%9D%D0%B5%D1%80%D0%BE%D0%B5%D0%B2%20%D0%92.%D0%92.%20%D0%91%D0%B5%D0%BB%D1%8B%D0%B5%20%D0%BD%D0%BE%D1%87%D0%B8%202024%20%D0%97%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%B5%D0%BC%D0%BE%D1%81%D1%82%D1%8C.pdf","key":"key-10.17116\/oftalma2024140061152-4"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-5","DOI":"10.15372\/SSMJ20180514"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-6","DOI":"10.25276\/2410-1257-2018-81-83"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-7","DOI":"10.32364\/2311-7729-2020-20-4-209-215"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-8","DOI":"10.1097\/IAE.0000000000004154"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-9","DOI":"10.1167\/iovs.65.10.24"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-10","DOI":"10.1007\/978-3-030-66014-7_4"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-11","DOI":"10.1167\/iovs.64.12.44"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-12","DOI":"10.57231\/j.ao.2023.1.1.037"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-13","DOI":"10.25276\/2312-4911-2019-1-260-263"},{"unstructured":"Klinicheskie rekomendacii \u00abMakuljarnaja degeneracija vozrastnaja\u00bb. 2024. Accessed 03.09.2024 (In Russ.). https:\/\/cr.minzdrav.gov.ru\/recomend\/114_3","key":"key-10.17116\/oftalma2024140061152-14"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-15","DOI":"10.1155\/2020\/7901270"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-16","DOI":"10.1016\/j.freeradbiomed.2018.11.035"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-17","DOI":"10.1016\/j.freeradbiomed.2024.03.024"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-18","DOI":"10.1007\/978-3-319-75402-4_2"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-19","DOI":"10.1080\/14728222.2020.1737015"},{"doi-asserted-by":"crossref","unstructured":"Levin LA. Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy. Surv Ophthalmol. 1999;43(Suppl 1):98-101","key":"key-10.17116\/oftalma2024140061152-20","DOI":"10.1016\/S0039-6257(99)00027-2"},{"unstructured":"Teplov DB. Molecular Biology of Neurodegenerative Diseases Visions for the Future-Part B. Academic Press; 2021","key":"key-10.17116\/oftalma2024140061152-21"},{"unstructured":"Kurysheva NI. Neiroprotektsiya i neiroregeneratsiya: perspektivy v lechenii glaukomy: monografiya. Moscow: Avtorskii tirazh; 2013 (In Russ.)","key":"key-10.17116\/oftalma2024140061152-22"},{"unstructured":"Alekseev IB, Ignat\u2019ev SA, Vorob\u2019eva IV, et al. Lechenie glaukomnoi opticheskoi neiropatii metodom endonazal\u2019nogo elektroforeza Korteksina: uchebno-metodicheskoe posobie. Moscow: RMAPO; 2014 (In Russ.)","key":"key-10.17116\/oftalma2024140061152-23"},{"unstructured":"Trofimova SV, Maksimov IB, Neroev VV. Regulyatornoe deistvie peptidov setchatki. St. Petersburg: Foliant; 2004 (In Russ.)","key":"key-10.17116\/oftalma2024140061152-24"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-25","DOI":"10.29296\/25877305-2021-05-16"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-26","DOI":"10.21516\/2072-0076-2016-9-1-39-46"},{"unstructured":"Stavitskaya TV, Egorov EA, Topchieva GV, et al. Comparison of neuroprotective properties of retinalamin and emoxipin. RMZh. Klinicheskaya oftal\u2019mologiya. 2004;5(3):108-111 (In Russ.)","key":"key-10.17116\/oftalma2024140061152-27"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-28","DOI":"10.18008\/1816-5095-2015-2-43-47"},{"unstructured":"Irshad M, Chaudhuri PS. Oxidant-antioxidant system: role and significance in human body. Indian J Exp Biol. 2002;40(11):1233-1239","key":"key-10.17116\/oftalma2024140061152-29"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-30","DOI":"10.3390\/cells10010064"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-31","DOI":"10.3390\/life13010077"},{"unstructured":"Egorov VV, Smolyakova GP, Danilova LP. Clinical and pharmacological aspects of neuroprotection of ischemic-hypoxic lesions of the optic nervous system of the eyes. Zdravookhranenie Dal\u2019nego Vostoka. 2014;(4):37-42 (In Russ.)","key":"key-10.17116\/oftalma2024140061152-32"},{"doi-asserted-by":"crossref","unstructured":"Shchul\u2019kin AV, Yakusheva EN, Chernykh IV. The distribution of mexidol in the rat\u2019s brain and its subcellular fractions. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2014;114(8):70-73 (In Russ.)","key":"key-10.17116\/oftalma2024140061152-33","DOI":"10.17116\/jnevro201411411240-43"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-34","DOI":"10.17116\/jnevro202012001162"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-35","DOI":"10.17116\/jnevro201811812287"},{"unstructured":"Shchul\u2019kin AV. Effect of mexidol on the development of the phenomenon of the neuronal excitotoxicity in vitro. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2012;112(2):35-39 (In Russ.)","key":"key-10.17116\/oftalma2024140061152-36"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-37","DOI":"10.17116\/oftalma2022138051126"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-38","DOI":"10.17116\/jnevro20171173255-65"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-39","DOI":"10.17116\/jnevro20211211117"},{"unstructured":"Egorov EA, Gvetadze AA, Davydova NG. Antioxidant agents in neuroprotection treatment of glaucoma. Russian Annals of Ophthalmology=Vestnik oftal\u2019mologii. 2013;129(2):67-69 (In Russ.)","key":"key-10.17116\/oftalma2024140061152-40"},{"unstructured":"Mukhamed\u2019yanova ASh, Aznabaev RA. Functional parameters of the organ of vision in patients with pre-inciform stage of age-related macular degeneration and hypertension during treatment with Mexidol. Tochka zreniya. Vostok \u2014 Zapad. 2011. Accessed 29.09.2024 (In Russ.). https:\/\/eyepress.ru\/article\/funktsional-nye-pokazateli-organa-zreniya-u-patsientov-s-predistsiformnoy-stadie","key":"key-10.17116\/oftalma2024140061152-41"},{"unstructured":"Egorov EA, Obruch BV, Oleinik AI, et al. The use of the drug Mexidol in patients with dystrophic diseases of the posterior segment of the eye. Klinicheskaya oftal\u2019mologiya. 2009;10(4):145-148 (In Russ.)","key":"key-10.17116\/oftalma2024140061152-42"},{"unstructured":"Malyshev VE, Sal\u2019nikova OI. The experience of using the drug \u201cMexidol\u201d in the complex outpatient treatment of patients with eye diseases of degenerative-dystrophic origin. Bjulleten\u2019 eksperimental\u2019noy biologii i meditsiny. 2006;(1):55-57 (In Russ.)","key":"key-10.17116\/oftalma2024140061152-43"},{"unstructured":"Malyshev VE, Sal\u2019nikova OI. The use of Mexidol in the treatment of primary open-angle glaucoma. Effektivnaya farmakoterapiya. 2022;18(11):52-56 (In Russ.)","key":"key-10.17116\/oftalma2024140061152-44"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-45","DOI":"10.1016\/j.exer.2006.12.010"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-46","DOI":"10.1001\/archopht.119.10.1417"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-47","DOI":"10.1001\/jama.2013.4997"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-48","DOI":"10.17116\/oftalma202013604186"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-49","DOI":"10.1016\/j.ophtha.2020.08.027"},{"doi-asserted-by":"publisher","key":"key-10.17116\/oftalma2024140061152-50","DOI":"10.3928\/23258160-20210528-05"}],"container-title":["Russian Annals of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T08:41:58Z","timestamp":1745397718000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/vestnik-oftalmologii\/2024\/6\/10042465X2024061152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12,28]]}},"alternative-id":["10.17116\/oftalma2024140061152"],"URL":"https:\/\/doi.org\/10.17116\/oftalma2024140061152","relation":{},"ISSN":["0042-465X"],"issn-type":[{"type":"print","value":"0042-465X"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}